Xencor, Inc. (XNCR)
25.16
+0.22
(+0.88%)
USD |
NASDAQ |
Oct 21, 16:00
25.50
+0.34
(+1.35%)
After-Hours: 20:00
Xencor Net Income (Annual) : -92.14M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -92.14M |
| December 31, 2024 | -236.54M |
| December 31, 2023 | -126.25M |
| December 31, 2022 | -55.18M |
| December 31, 2021 | 82.63M |
| December 31, 2020 | -69.33M |
| December 31, 2019 | 26.88M |
| December 31, 2018 | -70.41M |
| Date | Value |
|---|---|
| December 31, 2017 | -38.49M |
| December 31, 2016 | 23.62M |
| December 31, 2015 | -17.59M |
| December 31, 2014 | -16.42M |
| December 31, 2013 | 84.51M |
| December 31, 2012 | -8.594M |
| December 31, 2011 | -11.20M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 24.02M |
| UroGen Pharma Ltd. | -153.49M |
| MeiraGTx Holdings Plc | -114.20M |
| IDEAYA Biosciences, Inc. | -113.70M |
| Iovance Biotherapeutics, Inc. | -390.98M |